Overview

Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic Ewing's sarcoma or primitive neuroectodermal tumor.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Treatments:
Cisplatin
Etoposide
Etoposide phosphate
Criteria
DISEASE CHARACTERISTICS:

- Histologically confirmed Ewing's family tumor as characterized by the following:

- Positive MIC2 on immunohistochemistry OR

- Evidence of a chromosomal translocation involving the EWS gene by conventional
cytogenetics

- t(11; 22) translocation or variant OR

- Demonstration of EWS/FLI1 or EWS/ERG gene fusion by PCR or FISH

- Metastases outside the lung or pleura

- At least 1 measurable lesion outside of previously irradiated area

- No symptomatic or known CNS metastases

PATIENT CHARACTERISTICS:

Age:

- 15 to 65

Performance status:

- WHO 0-2

Life expectancy:

- Not specified

Hematopoietic:

- WBC at least 3,000/mm3

- Neutrophil count at least 2,000/mm3

- Platelet count at least 100,000/mm3

Hepatic:

- Bilirubin less than 3 mg/dL

- Albumin greater than 2.5 g/dL

Renal:

- Creatinine less than 1.2 mg/dL

- Creatinine clearance greater than 70 mL/min

Cardiovascular:

- No history of uncontrolled cardiovascular disease

Other:

- No other severe medical illness, including psychosis

- No other prior primary malignancy except adequately treated carcinoma in situ of the
cervix or basal cell skin cancer

- Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY:

Biologic therapy:

- Not specified

Chemotherapy:

- No prior chemotherapy

Endocrine therapy:

- Not specified

Radiotherapy:

- See Disease Characteristics

Surgery:

- Not specified